Literature DB >> 10591284

Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder.

.   

Abstract

BACKGROUND: Intent-to-treat analyses of the study revealed that medication management, alone or combined with intensive behavioral treatment, was superior to behavioral treatment and community care in reducing attention-deficit/hyperactivity disorder (ADHD) symptoms; but only combined treatment showed consistently greater benefit than community care across other outcome domains (disruptive and internalizing symptoms, achievement, parent-child relations, and social skills). We examine response patterns in subgroups defined by baseline variables (moderators) or variables related to treatment implementation (mediators).
METHODS: We reconducted random-effects regression (RR) analyses, adding factors defined by moderators (sex, prior medication use, comorbid disruptive or anxiety disorder, and public assistance) and a mediator (treatment acceptance/attendance).
RESULTS: Study outcomes (N = 579) were upheld in most moderator subgroups (boys and girls, children with and without prior medication, children with and without comorbid disruptive disorders). Comorbid anxiety disorder did moderate outcome; in participants without anxiety, results paralleled intent-to-treat findings. For those with anxiety disorders, however, behavioral treatment yielded significantly better outcomes than community care (and was no longer statistically different from medication management and combined treatment) regarding ADHD-related and internalizing symptoms. In families receiving public assistance, medication management yielded decreased closeness in parent-child interactions, and combined treatment yielded relatively greater benefits for teacher-reported social skills. In families with high treatment acceptance/attendance, intent-to-treat results were upheld. Acceptance/attendance was particularly important for medication treatments. Finally, two thirds of children given community care received stimulants. Behavioral treatment did not significantly differ from, but medication management was superior to, this subgroup.
CONCLUSIONS: Exploratory analyses revealed that our study (the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder [MTA]) results were confirmed across most baseline variables and treatment acceptance/attendance. In children with ADHD plus anxiety, behavioral treatment surpassed community care and approached medication-based treatments regarding parent-reported ADHD symptoms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10591284     DOI: 10.1001/archpsyc.56.12.1088

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  173 in total

Review 1.  New treatments and approaches for attention deficit hyperactivity disorder.

Authors:  J H Newcorn
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

Review 2.  Evidence-based treatment for mental disorders in children and adolescents.

Authors:  Gregory A Fabiano; William E Pelham
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

Review 3.  Comorbidity and child psychopathology: recommendations for the next decade.

Authors:  Peter S Jensen
Journal:  J Abnorm Child Psychol       Date:  2003-06

4.  The role of primary care physicians in attention-deficit/hyperactivity disorder.

Authors:  Laurel K Leslie
Journal:  Pediatr Ann       Date:  2002-08       Impact factor: 1.132

5.  What have we learned about trial design from NIMH-funded pragmatic trials?

Authors:  John March; Helena C Kraemer; Madhukar Trivedi; John Csernansky; John Davis; Terence A Ketter; Ira D Glick
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

6.  Examining How Context Changes Intervention Impact: The Use of Effect Sizes in Multilevel Mixture Meta-Analysis.

Authors:  C Hendricks Brown; Wei Wang; Irwin Sandler
Journal:  Child Dev Perspect       Date:  2008-11-28

Review 7.  Understanding attention-deficit/hyperactivity disorder from childhood to adulthood.

Authors:  Timothy E Wilens; Thomas J Spencer
Journal:  Postgrad Med       Date:  2010-09       Impact factor: 3.840

8.  Racial and Ethnic Differences in ADHD Treatment Quality Among Medicaid-Enrolled Youth.

Authors:  Janet R Cummings; Xu Ji; Lindsay Allen; Cathy Lally; Benjamin G Druss
Journal:  Pediatrics       Date:  2017-05-16       Impact factor: 7.124

9.  Treatment of attention deficit hyperactivity disorder in children. Predictors of treatment outcome.

Authors:  Saskia van der Oord; P J M Prins; J Oosterlaan; P M G Emmelkamp
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

10.  Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.

Authors:  Brooke S G Molina; Stephen P Hinshaw; L Eugene Arnold; James M Swanson; William E Pelham; Lily Hechtman; Betsy Hoza; Jeffery N Epstein; Timothy Wigal; Howard B Abikoff; Laurence L Greenhill; Peter S Jensen; Karen C Wells; Benedetto Vitiello; Robert D Gibbons; Andrea Howard; Patricia R Houck; Kwan Hur; Bo Lu; Sue Marcus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-02-08       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.